Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Cheng Chiang

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 7, 2010
Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinomaYu-Li Chen, Chih-Ming Ho, Chi-An Chen, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive ReviewMing-Cheng Chang, Cheng-Liang Peng, Chun-Tang Chen, et al.
The Journal of Sexual Medicine|May 6, 2026
Uncoupling anatomical barriers from radiotherapy toxicity: a two-part hurdle analysis of sexual function in gynecologic cancerCheng-Hsueh Kuo, Che-Yu Hsu, Yi-Jou Tai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 23, 2023
Prognostic nutritional index and neutrophil-lymphocyte ratio predict toxicities and prognosis in patients with cervical cancer treated with curative radiochemotherapyJenny Ling-Yu Chen, Chao-Yuan Huang, I-Lun Shih, et al.
Women'S Health Reports (New Rochelle, N.Y.)|January 30, 2025
Predicting Survival Outcomes for Patients with Ovarian Cancer Using National Cancer Registry Data from Taiwan: A Retrospective Cohort StudyAmrita Chattopadhyay, Ya-Ting Wu, Han-Ching Chan, et al.
Cancer Letters|March 30, 2018
Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturationYu-Li Chen, Ming-Cheng Chang, Ying-Cheng Chiang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|November 15, 2014
Establishment of a New Ovarian Cancer Cell Line CA5171Ying-Cheng Chiang, Wen-Fang Cheng, Ming-Cheng Chang, et al.
Journal of Gynecologic Oncology|October 30, 2013
Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in TaiwanYing-Cheng Chiang, Chi-An Chen, Chun-Ju Chiang, et al.
Histopathology|September 9, 2014
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expressionHsien-Neng Huang, Ming-Chieh Lin, Li-Hui Tseng, et al.
Epigenomics|October 17, 2018
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancerHan-Wei Lin, Chi-Feng Fu, Ming-Cheng Chang, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 7, 2010
Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinomaYu-Li Chen, Chih-Ming Ho, Chi-An Chen, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive ReviewMing-Cheng Chang, Cheng-Liang Peng, Chun-Tang Chen, et al.
The Journal of Sexual Medicine|May 6, 2026
Uncoupling anatomical barriers from radiotherapy toxicity: a two-part hurdle analysis of sexual function in gynecologic cancerCheng-Hsueh Kuo, Che-Yu Hsu, Yi-Jou Tai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 23, 2023
Prognostic nutritional index and neutrophil-lymphocyte ratio predict toxicities and prognosis in patients with cervical cancer treated with curative radiochemotherapyJenny Ling-Yu Chen, Chao-Yuan Huang, I-Lun Shih, et al.
Women'S Health Reports (New Rochelle, N.Y.)|January 30, 2025
Predicting Survival Outcomes for Patients with Ovarian Cancer Using National Cancer Registry Data from Taiwan: A Retrospective Cohort StudyAmrita Chattopadhyay, Ya-Ting Wu, Han-Ching Chan, et al.
Cancer Letters|March 30, 2018
Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturationYu-Li Chen, Ming-Cheng Chang, Ying-Cheng Chiang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|November 15, 2014
Establishment of a New Ovarian Cancer Cell Line CA5171Ying-Cheng Chiang, Wen-Fang Cheng, Ming-Cheng Chang, et al.
Journal of Gynecologic Oncology|October 30, 2013
Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in TaiwanYing-Cheng Chiang, Chi-An Chen, Chun-Ju Chiang, et al.
Histopathology|September 9, 2014
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expressionHsien-Neng Huang, Ming-Chieh Lin, Li-Hui Tseng, et al.
Epigenomics|October 17, 2018
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancerHan-Wei Lin, Chi-Feng Fu, Ming-Cheng Chang, et al.
Pageof 8